Cancer mutation gains ground as test for immunotherapy drugs

MADRID (Reuters) - Scientists are stepping up the hunt for better diagnostic tests to predict if cancer patients will benefit from costly modern immunotherapy drugs, which are transforming cancer care but remain a hit-and-miss affair.